• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Authors

Online ISSN: 2515-8260

Volume9, Issue7

Breast Cancer Nodal Staging- Reliability of Clinical Assessment with Core Biopsy

    Arpan Mishra Hari Damde Yogesh Tiwari

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 1903-1907

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Aim of this study to estimate the diagnostic accuracy of clinical assessment with ultrasound guided axillary node core needle biopsy (CNB) / fine needle aspiration cytology (FNAC) for axillary staging in early stage breast cancer. Materials and Methods: This prospective study was conducted in a tertiary care centre of central India in medical college hospital Jabalpur. We identified 64 consecutive patients of newly diagnosed early stage breast cancer. After clinical examination, ultrasound axilla guided core biopsy or fine needle aspiration cytology was performed if the node was in ultrasound. Axillary node dissection was performed in all patients. Preoperative and postoperative nodal positivity was compared and analysed. Results: Clinically and by ultrasound sensitivity and specificity of metastatic nodes was 50 and 75% and 75 and 83% respectively. False negative rate of our study was 6.2% that is equivalent to sentinel node biopsy. Sensitivity of guided FNAC/biopsy was 50 % in our study. Conclusion: Our study showed use of detailed clinical assessment is a good alternative where facility of sentinel node biopsy is not available. It is a good and less morbid alternative to sentinel node biopsy and if the result is positive can proceed directly to axillary node dissection
Keywords:
    breast cancer Axillary node core biopsy Axillary node fine needle aspiration cytology Nodal staging
  • PDF (414 K)
  • XML
(2022). Breast Cancer Nodal Staging- Reliability of Clinical Assessment with Core Biopsy. European Journal of Molecular & Clinical Medicine, 9(7), 1903-1907.
Arpan Mishra; Hari Damde; Yogesh Tiwari. "Breast Cancer Nodal Staging- Reliability of Clinical Assessment with Core Biopsy". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 1903-1907.
(2022). 'Breast Cancer Nodal Staging- Reliability of Clinical Assessment with Core Biopsy', European Journal of Molecular & Clinical Medicine, 9(7), pp. 1903-1907.
Breast Cancer Nodal Staging- Reliability of Clinical Assessment with Core Biopsy. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 1903-1907.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 31
  • PDF Download: 66
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus